InMode PE Ratio 2018-2025 | INMD
Current and historical p/e ratio for InMode (INMD) from 2018 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. InMode PE ratio as of November 10, 2025 is 10.32.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| InMode PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-11-10 | 14.60 | 8.02 | |
| 2025-09-30 | 14.90 | $1.82 | 8.19 |
| 2025-06-30 | 14.44 | $2.47 | 5.85 |
| 2025-03-31 | 17.74 | $2.33 | 7.61 |
| 2024-12-31 | 16.70 | $2.35 | 7.11 |
| 2024-09-30 | 16.95 | $1.85 | 9.16 |
| 2024-06-30 | 18.24 | $1.74 | 10.48 |
| 2024-03-31 | 21.61 | $2.11 | 10.24 |
| 2023-12-31 | 22.24 | $2.30 | 9.67 |
| 2023-09-30 | 30.46 | $2.10 | 14.50 |
| 2023-06-30 | 37.35 | $2.14 | 17.45 |
| 2023-03-31 | 31.96 | $2.01 | 15.90 |
| 2022-12-31 | 35.70 | $1.90 | 18.79 |
| 2022-09-30 | 29.11 | $2.07 | 14.06 |
| 2022-06-30 | 22.41 | $2.01 | 11.15 |
| 2022-03-31 | 36.91 | $1.97 | 18.78 |
| 2021-12-31 | 70.58 | $1.92 | 36.76 |
| 2021-09-30 | 79.73 | $1.74 | 45.95 |
| 2021-06-30 | 47.34 | $1.50 | 31.56 |
| 2021-03-31 | 36.19 | $1.13 | 32.02 |
| 2020-12-31 | 23.74 | $0.89 | 26.67 |
| 2020-09-30 | 18.09 | $0.70 | 26.03 |
| 2020-06-30 | 14.16 | $0.62 | 22.84 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.913B | $0.395B |
| InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $219.724B | 25.32 |
| EssilorLuxottica (ESLOY) | France | $166.677B | 0.00 |
| Boston Scientific (BSX) | United States | $148.274B | 33.90 |
| Stryker (SYK) | United States | $136.154B | 27.03 |
| Medtronic (MDT) | Ireland | $118.264B | 16.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.513B | 0.00 |
| Agilent Technologies (A) | United States | $41.601B | 26.92 |
| ResMed (RMD) | United States | $36.703B | 25.40 |
| GE HealthCare Technologies (GEHC) | United States | $33.276B | 15.91 |
| Koninklijke Philips (PHG) | Netherlands | $27.125B | 17.72 |
| Terumo (TRUMY) | Japan | $23.970B | 28.40 |
| Insulet (PODD) | United States | $22.513B | 69.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.539B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.183B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.495B | 0.00 |
| Baxter (BAX) | United States | $9.253B | 7.47 |
| Bio-Rad Laboratories (BIO) | United States | $8.242B | 29.64 |
| Demant (WILYY) | Denmark | $7.359B | 0.00 |
| ICU Medical (ICUI) | United States | $3.460B | 21.97 |
| Lantheus Holdings (LNTH) | United States | $3.387B | 10.32 |
| Haemonetics (HAE) | United States | $3.200B | 14.24 |
| Envista Holdings (NVST) | United States | $3.198B | 18.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.883B | 13.15 |
| Perrigo (PRGO) | Ireland | $1.987B | 4.98 |
| LeMaitre Vascular (LMAT) | United States | $1.965B | 39.64 |
| Curaleaf Holdings (CURLF) | Canada | $1.793B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.774B | 17.72 |
| AtriCure (ATRC) | United States | $1.593B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.449B | 63.49 |
| Tilray Brands (TLRY) | Canada | $1.392B | 0.00 |
| Neogen (NEOG) | United States | $1.391B | 26.67 |
| QuidelOrtho (QDEL) | United States | $1.382B | 8.89 |
| Kestra Medical Technologies (KMTS) | United States | $1.349B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.285B | 18.63 |
| BioLife Solutions (BLFS) | United States | $1.242B | 370.43 |
| Valneva SE (VALN) | France | $0.750B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.497B | 17.10 |
| Verano Holdings (VRNO) | United States | $0.478B | 0.00 |
| SNDL (SNDL) | Canada | $0.468B | 0.00 |
| Omeros (OMER) | United States | $0.448B | 0.00 |
| CeriBell (CBLL) | United States | $0.444B | 0.00 |
| Evolus (EOLS) | United States | $0.425B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.381B | 0.00 |
| Cerus (CERS) | United States | $0.328B | 0.00 |
| Brainsway (BWAY) | Israel | $0.296B | 59.96 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.281B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.267B | 0.00 |
| High Tide (HITI) | Canada | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 151.67 |
| Sanara MedTech (SMTI) | United States | $0.247B | 0.00 |
| Owens & Minor (OMI) | United States | $0.246B | 2.47 |
| Viemed Healthcare (VMD) | United States | $0.242B | 19.30 |
| Quanterix (QTRX) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.219B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Organigram Global (OGI) | Canada | $0.206B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 16.22 |
| FitLife Brands (FTLF) | United States | $0.172B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.172B | 0.00 |
| Apyx Medical (APYX) | United States | $0.148B | 0.00 |
| Biote (BTMD) | United States | $0.134B | 5.42 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Sharps Technology (STSS) | United States | $0.109B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.107B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 11.95 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| MacroGenics (MGNX) | United States | $0.087B | 0.00 |
| Agape ATP (ATPC) | $0.062B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.10 |
| Nephros (NEPH) | United States | $0.049B | 35.38 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Jin Medical (ZJYL) | China | $0.042B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Bonk (BNKK) | United States | $0.033B | 0.00 |
| Zynex (ZYXI) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.77 |
| Modular Medical (MODD) | United States | $0.029B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |